Ben Van Baelen
Herent, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinical Presentation, Treatment Response, and Virology Outcomes of Women Who Seroconverted in the Dapivirine Vaginal Ring Trials-The Ring Study and DREAM.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 19, 2022
Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 19, 2022
Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study.
Journal: The lancet. HIV
Published: April 28, 2020
Triplicate Sputum Cultures for Efficacy Evaluation of Novel Antituberculosis Regimens.
Journal: American journal of respiratory and critical care medicine
Published: April 28, 2017
More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.
Journal: The New England journal of medicine
Published: December 30, 2016
Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women.
Journal: The New England journal of medicine
Published: December 14, 2016
Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial.
Journal: SAGE open medicine
Published: June 17, 2016
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis.
Journal: The European respiratory journal
Published: May 08, 2015
Comparison of genotypic and phenotypic HIV type 1 tropism assay: results from the screening samples of Cenicriviroc Study 202, a randomized phase II trial in treatment-naive subjects.
Journal: AIDS research and human retroviruses
Published: July 24, 2013
Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypes.
Journal: Journal of viral hepatitis
Published: June 01, 2012
Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure: results from the REALIZE trial.
Journal: Hepatology (Baltimore, Md.)
Published: February 28, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026